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Abstract 
Stress often precedes the onset of mental health disorders and is linked to negative 
impacts on physical health as well. Prior research indicates that testosterone levels are related to 
reduced stress reactivity in some cases but correlate with increased stress responses in other 
cases. To resolve these inconsistencies, we tested the causal influence of testosterone on stress 
reactivity to a social-evaluative stressor. Further, prior work has failed to consider status-relevant 
individual differences such as trait dominance that may modulate the influence of testosterone on 
responses to stressors. Participants (n = 120 males) were randomly assigned to receive 
exogenous testosterone or placebo (n = 60 testosterone treatment group) via topical gel prior to a 
well-validated social-evaluative stressor. Compared to placebo, testosterone significantly 
increased cortisol and negative affect in response to the stressor, especially for men high in trait 
dominance (95% confidence intervals did not contain zero). The findings suggest that the 
combination of high testosterone and exposure to status-relevant social stress may confer 
increased risk for stress-mediated disorders, particularly for individuals high in trait dominance. 
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1.1 Introduction 
Stress is a leading contributor to poor health and mortality: Exposure to chronic or severe 
stress predicts increased risk for cardiovascular disease, psychiatric conditions such as 
depression and substance use disorders, and infectious disease (McEwen, 2004; Hammen, 2005; 
Stephens & Wand, 2012). Cortisol, a steroid hormone released as part of the hypothalamic-
pituitary-adrenal (HPA) axis response to stress, mediates adaptive responses to stressors in the 
short term – for example, by stimulating gluconeogenesis to provide energy to respond to and 
recover from a stressor (McEwen, 2004). But in the context of chronic or severe stressors, 
cortisol can negatively impact physical and mental health via dysregulation of immune system 
activity and neurotoxic effects within the central nervous system (McEwen, 2004; Cohen et al., 
2012; Sapolsky, 2000). Stress also heightens negative affect, which is an independent pathway 
that predicts poor mental and physical health (Hammen, 2005; Kiecolt-Glaser et al., 2002).  
Because of these potential consequences for physical and mental health, the systems that 
modulate responses to stressors are of great importance for understanding relationships between 
stress, health, and well being. Prevailing theories propose that the sex hormone testosterone 
should reduce stress responses, but the causal effect of testosterone on stress reactivity in humans 
remains unclear. In animal (e.g., rodent) models of stress, testosterone reduces cortisol reactivity 
to stress (Viau & Meaney, 2004) and reduces fear behavior (Aikey et al., 2002). Consistent with 
this stress-buffering account, in humans, testosterone suppresses cortisol responses to 
pharmacological stimulation of the HPA axis in men (Rubinow et al., 2005), and reduces 
unconscious attention to fearful faces in women (van Honk et al., 2005). Yet other studies 
indicate that testosterone correlates with increased cortisol and negative affect in response to 
situations that threaten social status, like losing a competition (Mehta et al., 2008; Zilioli & 
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Watson, 2013) or being relegated to a low-ranking social position (Josephs et al., 2006). This 
correlational evidence is convergent with theorizing that testosterone directs the pursuit and 
maintenance of social status (Mazur & Booth, 1998) and suggests that testosterone may enhance 
acute stress responses when the stressor relates to social status, like during a social evaluation for 
a high-status job.  
Despite this correlational evidence, the causal effects of testosterone on responses to 
status-relevant social stress have not been adequately tested in healthy young adults1. Further, the 
few correlational studies that have examined testosterone and social stress have provided mixed 
evidence linking testosterone levels to both increased (Juster et al., 2016) and decreased 
(Stephens et al., 2016) cortisol output. In order to clarify this inconsistent correlational evidence, 
we provide a direct causal test of testosterone’s impact on cortisol and negative affect responses 
to stress using a status-relevant social stressor. We hypothesize that testosterone alters these 
stress responses, but because of the mixed correlational evidence, we are agnostic with regards to 
the direction of the effect. Moreover, given the increasing rate at which testosterone is prescribed 
(Baillargeon et al., 2013), administering testosterone prior to a social-evaluative stressor will 
provide much needed insight into testosterone’s potential impact on stress and health. 
Prior research also indicates that testosterone’s effects on status-relevant behavior depend 
on trait dominance, an individual difference factor relevant to concern for status attainment, but 
the interactive effects of testosterone and dominance on stress responses is unknown. High levels 
of trait dominance, marked by a propensity to use force, fear, or intimidation to gain high-
ranking positions within social groups (Cheng et al., 2013), correlate with increased 
                                                        
1 But cf. Rohleder et al. (2002), for a small sample of older men that found no difference in 
cortisol responses to an acute stressor several days after a single dose of testosterone vs. placebo. 
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cardiovascular stress reactivity (Lee & Hughes, 2014) and accentuate the behavioral effects of 
testosterone in status-relevant situations. For example, exogenous testosterone increases men’s 
aggression after provocation (Carré et al., in press) and increases women’s competitive behavior 
after winning a contest (Mehta et al., 2015), but only in individuals high in self-reported trait 
dominance. These behavioral results suggest that trait dominance may also exacerbate the 
influence of high testosterone levels on responses to status-relevant stressors. 
2. Materials and Methods 
2.1 Participants 
Male participants (n = 120) between the ages of 18-40 (Mean = 22.50 years; SE = 0.33) 
were recruited via emailing campus listservs and by placing flyers on and near campus. 
Interested parties were screened for medical conditions that would prevent participation in the 
study, including immune, endocrine, neurological, or mental health conditions, and alcohol or 
drug abuse (see Supplemental Materials). The University of Oregon’s Institutional Review 
Board approved all methods. 
2.2 Protocol 
2.2.1 Participants and Recruitment. After passing screening, the participant chose a 
day (Monday–Saturday) to attend a six-hour laboratory session, which began between 9:00–
11:00 AM. These times were chosen so that the stressor would occur between 1:00–3:00 PM to 
control for diurnal endocrine variation. Participants were asked to refrain from eating or drinking 
anything except water or brushing their teeth 1.5 hours prior to the start of the session. Upon 
arrival at the session, experimenters obtained informed consent from the participant (see Figure 
1 for a study timeline of saliva sampling and self-report data collection). Participants were paid 
$60 for completing the laboratory session. 
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2.2.2 Gel Application and Blinding. This study was executed as a between-groups, 
placebo-controlled experimental design. Testosterone and placebo doses (n = 60 in each group) 
were randomly ordered prior to data collection by members of our laboratory who were 
unaffiliated with this research. Participants were given a sealed enveloped which either revealed 
that the gel was testosterone or placebo – a single-blind condition – or simply stated that he had 
an equal chance of receiving testosterone or placebo – a double-blind condition. These blinding 
conditions were implemented to control for the expectancy effects (i.e., ‘conventional wisdom’) 
of receiving testosterone (Eisenegger et al., 2010). A laboratory member uninvolved in data 
collection prepared the envelopes prior to the start of data collection, thus the experimenter in the 
laboratory session never knew whether the vial contained testosterone or placebo, or to which 
blinding condition the participant was assigned. 
Under the supervision of the experimenter, the participant rubbed increments of the gel 
onto his own shoulders and upper arms. The participant was then given several minutes to read 
the contents of the envelope, during which the gel dried.  
2.2.3 Pharmacological Manipulation. The testosterone gel (AbbVie, Chicago, IL) 
consisted of a 150-mg dose of testosterone in addition to pharmacologically inactive ingredients 
(see Supplemental Materials). The placebo gel contained the same inactive ingredients as the 
testosterone gel; the lack of testosterone was the only difference between the gels. The 
testosterone dose and time course for this protocol was based on prior topical-testosterone-
administration research that showed serum testosterone concentrations peaked 3 hours after a 
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150-mg testosterone dose (Eisenegger et al., 2013)2. Prior research has also shown physiological 
and neural reactivity 3-6 hours after testosterone administration3 (Tuiten et al., 2000, Radke et 
al., 2015). In order to execute our protocol during peak concentrations and within a 6-hour time 
period, this project utilized a 150-mg dose of testosterone approximately four hours (Mean=3.98 
hours, SE=0.015 hours) prior to the social-evaluative stressor. 
2.2.4 Social-Evaluative Stressor. The social-evaluative stressor (the Trier Social Stress 
Test, or TSST; Kirschbaum et al., 1993) consisted of a mock job interview for a high-status, 
managerial position followed by a verbal mental math task. The job was described in a printed 
document and was designed to be representative of an early-career position consisting of 
managing a small team (i.e., twelve student employees) in a campus business office. Two 
panelists wearing white lab coats conducted the interview. These panelists were trained to 
maintain neutral affect and behavior throughout the task. For a majority of participants (72.5%), 
the panel was mixed gender; the remaining panels were composed of two male or two female 
panelists (24.2% male panelists; 3.33% female panelists; see Supplemental Materials for 
evidence that panelist gender did not alter results). 
2.2.5 Other tasks. The study protocol contained three decision-making paradigms prior 
to the social-evaluative stressor in order to maximize data obtained from each participant 
undergoing exogenous testosterone administration; all will be analyzed and reported elsewhere. 
                                                        
2 See Bird et al. (2016) and Carré et al. (2015) for work published after this data was collected 
that shows that peak testosterone concentrations occur earlier, approximately sixty minutes after 
topical gel administration. 
3 This prior research was conducted on women using sublingual testosterone and so may have 
questionable value for experimental studies involving topical testosterone in men. As above, we 
recommend Bird et al. (2016) and Carré et al. (2015) for more up-to-date methods for topical 
testosterone administration. 
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Participants could earn bonus money based on their performance in two of these tasks, though 
the exact amount earned was not revealed until the end of the laboratory session.  
2.3 Questionnaires 
 2.3.1 Dominance and Prestige Scale. Trait dominance was indexed from a scale that 
measures dominance aspects of status-seeking motivation, related to obtaining status via force, 
fear, or intimidation, and prestige motivations, which are related to obtaining status via 
competence, social skills, or respect (Cheng et al., 2013). The survey – which has been shown to 
be valid and reliable (Cheng et al., 2010) – consists of 17 items related to dominance (e.g., “I try 
to control others rather than permit them to control me.”) and prestige (e.g., “Members of my 
peer group respect and admire me.”) on a scale from 1 (not at all) to 7 (very much). Dominance 
(Cronbach’s α = .68) and prestige items (Cronbach’s α = .83) were averaged and normalized 
within each subscale. 
 2.3.2 Positive and Negative Affect. The PANAS-X general negative and general 
positive affect subscales were used to measure affect responses. Participants responded on a 1 
(not at all or very little) to 4 (quite a bit) scale. Negative (average Cronbach’s α = 0.89) and 
positive (average Cronbach’s α = 0.84) items were averaged for each time point according to 
published guidelines (Watson & Clark, 1994). We also conducted exploratory analyses on the 
subscales that underlie general negative affect (fear, hostility, guilt, sadness) and general positive 
affect (joviality, self-assurance, attentiveness). 
2.4 Saliva Sampling and Endocrine Assays 
The cortisol response to stress was determined from saliva samples collected immediately 
before (i.e, pre-TSST) and +0, +20, and +40 minutes after the stressor (see Supplementary 
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Materials for analyses of samples that occurred prior to gel application (morning baseline) and 
three hours after gel application, Figures S1-S3). For saliva collection, participants were 
instructed to drool 2 mL of saliva into polypropylene centrifuge tubes. Saliva samples were 
assayed in duplicate for cortisol and testosterone in our laboratory using commercially available 
enzyme immunoassay (EIA) kits (DRG International; see Supplemental Materials for details). 
The average intra-assay coefficients of variation (CVs) were 4.68% (cortisol) and 6.55% 
(testosterone); the inter-assay CVs were 14.8% (cortisol) and 16.1% (testosterone) averaged 
across low and high control samples. 
Testosterone administration resulted in testosterone levels that exceeded the EIA kits’ 
maximum (5250 pg/mL) in 34.4% of samples within the testosterone group (17% of all samples; 
no samples in placebo condition were above threshold). As a conservative estimate of the 
testosterone concentrations, we replaced these unknown values with the EIA kit’s maximum 
value, 5250 pg/mL. If one of the duplicate samples was within the kit’s range, we averaged that 
known value with the maximum. All analyses were chosen a priori to focus on testosterone 
treatment as a categorical variable. This data replacement strategy therefore provides a low-end 
estimate of testosterone concentration in order to confirm that testosterone treatment sufficiently 
raised testosterone concentrations. Given this conservative estimate, any significant differences 
can be extrapolated to be true for a test if the actual concentrations were known (see 
Supplemental Materials for further justification of this approach). 
 2.5 Analytical Plan 
 Multi-level models were constructed to examine Time x Testosterone vs. Placebo (T/P) 
and Time x T/P x Dominance effects on cortisol and negative affect responses to social-
evaluative stress (see Supplementary Materials for full models). T/P condition was effects coded 
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(Testosterone = 1, Placebo = -1). All analyses controlled for participant blinding condition (see 
Supplemental Materials for analyses of blinding and ). Ninety-five percent confidence intervals 
(95%CIs) of the model estimates were used to determine the magnitude and direction of the 
effects. Relying on these model interpretations avoids some of the issues inherent to interpreting 
p-values as part of null hypothesis testing (Cummings, 2014). 
In order to confirm interpretations of the multilevel models of the cortisol response, we 
conducted a GLM analysis on area-under-the-curve with respect to increase (AUCI), a measure 
of cortisol reactivity that takes into account all four samples (Pruessner et al., 2003). Simple 
slope analyses were used to decompose interactions (Preacher et al., 2006).  
3. Results 
3.1 Preliminary Analyses 
Four participants (n = 2 from testosterone treatment group) did not complete the social-
evaluative stressor and were excluded from analyses. Two additional participants were missing a 
single sample – one participant left the laboratory prior to completing the TSST+40 sample and 
one participant’s sample was improperly aliquoted during the assay process – but these 
participants were left in the analyses as multilevel models are generally able to account for 
singular missing data points. Outliers (>3 SD) for negative affect were found at each time point 
(Baseline: n = 2; Pre-TSST: n = 3; Post-TSST: n = 1); these values were Winsorized to a score 3 
SD above the mean for each time point. See Table S1 for descriptive statistics and correlations 
(Supplemental Materials). 
As expected, the testosterone gel substantially increased testosterone concentrations 
(mean of post-gel testosterone concentrations, Testosterone group: M = 2959.87 pg/mL, 
95%CI[2472.46, 3447.28]; Placebo group: M = 164.00 pg/mL, 95%CI[122.99, 205.01]; see 
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Supplementary Materials, Figure S3). No differences in pre-TSST cortisol or baseline affect 
were found between treatment groups or in exploration of interactions between treatment group 
and trait dominance (see Supplementary Materials). 
3.2 Cortisol Response to Stress 
Examining the impact of exogenous testosterone on cortisol concentrations across time 
revealed a Time x Testosterone/Placebo (T/P) condition interaction, such that exogenous 
testosterone increased cortisol responses to the social-evaluative stressor compared to placebo 
(Time x T/P: B = 0.020, 95%CI[0.001, 0.038]; Time2 x T/P: B = -0.013, 95%CI[-0.031, 0.005]; 
Figure 2A, Table S2, Supplementary Materials).  
This Time x T/P interaction was moderated by trait dominance (Time x T/P x 
Dominance: B = 0.020, 95%CI[0.002, 0.038]; Time2 x T/P x Dominance: B = -0.021, 95%CI[-
0.039, -0.003]; Figure 2B). Decomposing these interaction terms with simple slope analyses 
revealed that high dominant men given testosterone showed a robust increase in cortisol due to 
the stressor (Time: B = 0.101, 95%CI[.064, 0.137]; Time2: B = -0.132, 95%CI[-0.169, -0.097]) 
compared to high dominant men given placebo, who displayed a relatively flat cortisol response 
(Time: B = 0.022, 95%CI[-0.014, 0.058]; Time2: B = -0.066, 95%CI[-0.101, -0.030]). Low trait 
dominant men given testosterone (Time: B = 0.064, 95%CI[0.028, 0.100]; Time2: B = -0.084, 
95%CI[-0.120, -0.049]) or placebo (Time: B = 0.065, 95%CI[0.028, 0.101]; Time2: B = -0.100, 
95%CI[-0.137, -0.064]) were essentially equivalent in terms of their cortisol response to the 
stressor.  
Follow-up analyses on cortisol AUCI confirmed this overall pattern of results: 
Testosterone treatment predicted increased AUCI (B = 0.073, 95%CI[0.007, 0.358]), but this was 
moderated by trait dominance (B = 0.077, 95%CI[0.013, 0.141]; Table S3; see Supplemental 
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Materials for simple slope analyses). For men high in trait dominance, testosterone increased 
cortisol AUCI compared to placebo; no differences were evident for low trait dominant men 
(Figure 3; see Supplemental Materials for reactivity and recovery analyses, Figure S4). Trait 
prestige levels did not interact with T/P to predict cortisol levels (Tables S4). 
3.3 Positive and Negative Affect Responses  
Testosterone increased negative affect in anticipation of the stressor compared to placebo 
(Time x T/P: B = 0.050, 95%CI[-0.010, 0.111]; Time2 x T/P: B = -0.044, 95%CI[-0.088, -0.001]; 
Figure 4A). Testosterone’s causal increase of negative affect across time was also moderated by 
trait dominance (Time x T/P x Dominance: B = 0.080, 95%CI[0.021, 0.139]; Time2 x T/P x 
Dominance: B = -0.036, 95%CI[-0.079, 0.007]; Figure 4B; Table S5, Supplementary 
Materials). Simple slope analyses revealed that for men high in trait dominance, testosterone 
(Time: B = 0.324, 95%CI[0.206, 0.443]; Time2: B = -0.229, 95%CI[-0.315, -0.143]) increased 
negative affect in response to the stressor compared to placebo (Time: B = 0.066, 95%CI[-0.051, 
0.183]; Time2: B = -0.068, 95%CI[-0.153, 0.017]). Low trait dominant men given testosterone 
(Time: B = 0.148, 95%CI[0.029, 0.267]; Time2: B = -0.160, 95%CI[-0.246, -0.073]) or placebo 
(Time: B = 0.209, 95%CI[0.090, 0.329]; Time2: B = -0.144, 95%CI[-0.231, -0.058]) showed 
increased negative affect in response to the stressor, but were essentially equivalent in terms of 
their negative affect in response to the stressor. Thus, testosterone enhances negative affect in 
response to a forthcoming social stressor and sustains this negative response to the stressor for 
individuals high in trait dominance.  
Follow-up analyses revealed that the effects of testosterone among high-dominance men 
were also seen on two specific subscales of negative affect, fear and hostility (Table S6, Figure 
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S5). Trait prestige levels were not found to moderate the effect of testosterone on negative affect 
in response to the stressor (Table S7). 
Positive affect decreased in response to the social-evaluative stressor (Time: B = -0.437, 
95%CI[-0.503, -0.371]), but neither testosterone nor the interaction of testosterone and trait 
dominance moderated this effect (all 95%CIs contain zero; Table S8). 
4. Discussion 
This study provides causal evidence that exogenous testosterone increases cortisol 
concentrations and negative affect in response to a social-evaluative stressor, especially for 
individuals with high trait dominance. For an individual high in trait dominance – who is already 
predisposed to being concerned with status and accustomed to wielding social or even physical 
force to obtain it – exogenous testosterone administration motivates strong concern for his status, 
making him vigilant for cues to potential threats. Indeed, testosterone increases neural reactivity 
and behavioral responses to threatening interpersonal cues that may signal an impending social 
challenge, like angry faces (Goetz et al., 2014; Hermans et al., 2008; Terburg et al., 2012). This 
increased concern for status during a social evaluation may be driving the dominant individual 
with high testosterone levels to feel more negative affect and elicit a stronger physiological 
response to the stressor. The present work therefore advances theory on testosterone and social 
status (Mazur & Booth, 1998) and challenges medical assumptions of testosterone’s stress-
suppressant effects by showing that testosterone’s influence on susceptibility to status threat 
extends to acute social-evaluative stress. Future work that investigates the effects of testosterone 
on stress responses must (i) consider the social context in which the stressor exists and (ii) 
account for individual differences in relevant psychosocial constructs like trait dominance.  
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In addition to these psychosocial explanations, careful consideration must be given to the 
potential biological mechanisms by which testosterone increases stress responses. Testosterone 
has been linked to increased activity in brain areas sensitive to threatening stimuli, such as the 
amygdala (Goetz et al., 2014). In animal research the amygdala is a key neural component that 
promotes HPA responses to stress (Herman et al., 2005), with limited work suggesting it may 
influence human responses well (Dedovic et al., 2009). Testosterone is also associated with 
reduced connectivity within frontal-limbic neural circuitry, a pattern thought to indicate 
decreased neural regulation of affect and behavioral responses to threat (Volman et al., 2011; van 
Wingen et al., 2010). Although currently untested, an individual with high testosterone levels 
who is high in trait dominance in the midst of a social evaluation may therefore experience 
increased activation and reduced regulation of these neural threat responses as part of an 
exacerbated response to the stressor.  
4.1 Future Directions 
The present study provides clear evidence of testosterone’s direct effects on stress 
responses and the moderating influence of trait dominance, but several facets must be explored 
in future work. First, this study used a prescription-strength dose of testosterone in order to 
supersede naturally occurring testosterone levels in eugonadal men. Future work must ensure 
testosterone’s causal effects are robust at naturally occurring concentrations, which could be 
accomplished by blocking gonadal endocrine functioning prior to administering testosterone to 
normal physiological ranges (Goetz et al., 2014).  
Second, although we provide evidence of testosterone’s direct effects on stress responses, 
the broader gonadal endocrine system should continue to be explored with regards to stress 
responses. For example, some of testosterone’s effects within the central nervous system depend 
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on local conversion to estrogen metabolites such as estradiol (Naftolin, 1994). Further, estradiol 
administered to men has been shown to increase HPA-axis responses to stress (Kirschbaum et 
al., 1996). Thus the effects reported here may depend on estradiol conversion, but future research 
must rigorously test this dependency in humans by blocking testosterone conversion to estradiol 
or antagonizing estrogen receptors. 
Third, based on the extant literature (Carré et al., in press; Mehta et al., 2015; Slatcher et 
al., 2011), we focused on trait dominance but future work should examine other possible 
moderators relevant to stress, testosterone, and social-status motivations. These putative 
moderators may include Type A/B personality, which may relate to trait dominance and 
correlates with stress-linked health outcomes (Pittner et al., 1983), as well as other factors that 
have been previously shown to moderate testosterone’s behavioral effects, like trait impulsivity 
(Carré et al., in press) or 2D:4D digit ratio, a presumptive index of prenatal androgen exposure 
(van Honk et al., 2011). 
Finally, the present study was limited to men due to constraints on the use of 
prescription-strength testosterone, but future research must consider the effects of testosterone 
and dominance on women’s stress responses. Prior work has shown that neural responses to 
threat are similar for men and women given exogenous testosterone (Hermans et al., 2008; Goetz 
et al., 2014) and, more broadly, that the interactive effects of exogenous testosterone and trait 
dominance alter women’s status-relevant behavior (Mehta et al., 2015). But women’s status-
seeking motivations may be more dependent on other sex hormones, such as estradiol (Stanton & 
Schultheiss, 2007), suggesting that a broader examination of gonadal hormones is warranted for 
men and women.  
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In summary, future work must investigate the extent to which stress responses are 
causally enhanced by physiologically normal ranges of testosterone and other gonadal hormones 
like estradiol, while exploring an array of status-relevant moderators of stress responses in men 
and women. 
4.2 Conclusions 
These results have important implications for understanding testosterone’s role in stress 
and health and may provide mechanistic insights for the clinical science of stress-linked 
disorders. Stress often precedes the onset of psychiatric conditions, like depression and substance 
use disorders (Hammen, 2005; Stephens & Wand, 2012). Individuals high in trait dominance 
with high testosterone levels may therefore be susceptible to stress-linked disorders like mood or 
substance abuse disorders due to increased reactivity to social stress. In support of this inference, 
dominance motivations have been theorized to share common etiology for externalizing 
psychopathologies with known links to stress exposure, such as drug and alcohol abuse (Johnson 
et al., 2012). In comparison to dominance, evidence of testosterone’s relationship with mental 
health is mixed: One large study found that above-average testosterone levels correlated with 
depressive symptoms, though controlling for protective psychosocial factors like marriage or 
employment attenuates this relationship (Booth et al., 1999a). But this same work and other 
research shows that lower testosterone levels (i.e., hypogonadism) are also associated with 
depressive symptomology (Booth et al., 1999a; Ford et al., 2016; Giltay et al., 2017), which 
testosterone treatment may improve (Snyder et al., 2016). Given this evidence of increased 
symptomatology at high and low testosterone levels, the present results may be one end of a U-
shaped relationship between testosterone and stress. Future work must therefore clarify the 
clinical significance of testosterone by continuing to examine the causal and moderating 
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pathways by which these biological and psychosocial factors affect the onset and course of 
mental health disorders via alterations in stress responses. 
In terms of physical health, exogenous testosterone is increasingly prescribed to treat 
hypogonadism (Baillargeon et al., 2013) and is associated with improved cardiovascular health 
(Alexander et al., 2017). Some limited evidence indicates that endogenous testosterone may 
relate to physical health in an inverted U-shape, with increased health complaints at high and low 
concentrations (Booth et al., 1999b), while other evidence suggests exogenous testosterone may 
actually boost the risk of non-fatal heart attacks (Finkle et al., 2014; cf. Corona et al., 2014 for 
alternative explanations of these findings). To date, none of this work has considered the 
potential ramifications testosterone may have for stress-related health conditions when 
considered within a psychosocial context. Our findings show that in response to a social stressor, 
testosterone increases cortisol levels and negative affect, which are both theorized pathways for 
downstream negative consequences of stress such as poor cardiovascular health (McEwen, 2004; 
Cohen et al., 2012; Sapolsky, 2000; Kiecolt-Glaser et al., 2002) and increased risk for acute 
cardiac events such as a heart attack (Steptoe & Kivimäki, 2012). It should be noted that an acute 
stress response in itself is not unhealthy. For example, cortisol and negative affect could provide 
metabolic energy and motivation to gain a high status position within a stressful social setting. 
But in the long term, over repeated stressors, testosterone’s causal increase of these stress 
responses may represent a liability to health and well-being, particularly for dominant 
individuals (McEwen, 2004). These results advocate strongly for the inclusion of psychosocial 
variables like trait dominance in future biomedical and clinical studies on the effects of 
testosterone on stress and stress-linked health outcomes. 
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Figure 1: Timeline of the experimental protocol for the present report. All timings are 
approximate and are represented in minutes relative to the end of the social-evaluative stressor. 
“TSST intro.” represents the instructions for the social-evaluative stress procedure. Two saliva 
samples were collected prior to the TSST-relevant samples: At baseline (prior to gel application) 
and three hours after gel application (see Supplemental Materials). 
Figure 2: Cortisol response to social-evaluative stress. All values are estimated marginal means 
from relevant models and all error bars are 95% confidence intervals. Panel A. Time x 
Testosterone vs. Placebo (T/P) effect on cortisol response. Panel B. Time x T/P effect on cortisol 
response graphed at ±1 SD trait dominance.  
Figure 3: Cortisol response to stress as indexed by AUCI. All values are estimated marginal 
means from relevant models and all error bars are 95% confidence intervals. Panel A. Main 
effects of T/P on cortisol AUCI. Panel B. Interactive effects of T/P x trait dominance on cortisol 
AUCI. * = group means differ with 95% confidence (i.e., interval of one group’s mean does not 
include the other group’s mean). 
Figure 4: Negative affect response to social-evaluative stress. All values are estimated marginal 
means from relevant models and all error bars are 95% confidence intervals. In each graph, “Pre-
TSST” was measured after giving instructions for the social-evaluative stress task but before 
beginning the task and is therefore a measure of anticipatory negative affect. Panel A. Time x 
T/P on negative affect. Panel B. Time x T/P effect on negative affect graphed at ±1 SD trait 
dominance. 
 
